Hurricane Beryl made landfall on the Texas coast and caused significant damage and flooding in numerous counties earlier this month, forcing many to evacuate to temporary locations. The Health and Human Services Commission (HHSC) will allow pharmacies to override prescription claims rejected with error codes 79 (Refill Too Soon) or 76 (Plan Limitations Exceeded) for people enrolled in fee-for-service Medicaid, the Children with Special Health Care Needs Services Program and the Kidney Health Care Program that pharmacies identify as affected by Hurricane Beryl. For people enrolled in Medicaid managed care or CHIP, pharmacies should contact the person’s managed care organization (MCO) for instruction. Refer to the MCO Search for each MCO’s contact information and billing codes. Pharmacies can call the Texas Medicaid Pharmacy and Technical Call Center at 800-435-4165, Monday through Friday from 7:00 am to 7:00 pm (central time) to request the override.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Acting on behalf of Gov. Greg Abbott (R) while he is out of the country on a trade mission, Lt. Gov. Dan Patrick (R) declared a Disaster Declaration for 121 counties impacted by Hurricane Beryl. The Board of Pharmacy’s Executive Director/Secretary Daniel R. Carroll, PharmD, RPh, has again authorized pharmacists in Texas to dispense up to a 30-day supply of medication (other than a Schedule II controlled substance) for patients affected in the counties of the disaster area. Board rule 291.34(b)(8)(E) outlines the procedures for dispensing medication in emergency situations.

Also in Texas, the next hybrid meeting of the Texas Pharmaceutical Initiative Board will be at 1:00 pm on July 16.

Also in Texas, the Health and Human Services Commission (HHSC) Vendor Drug Program (VDP) will perform the semi-annual update of the Medicaid preferred drug list on July 25, based on the recommendations made at two meetings of the Texas Drug Utilization Review early this year.

Finally in Texas, The Texas Drug Utilization Review Board agenda for July 26 is now available. Refer to the Texas Drug Utilization Review Board Handbook for instructions on submitting written materials to the board before the meeting and public testimony on the day of the meeting. People providing written or public testimony must complete the appropriate testimony form and the Public Comment Registration form linked on the agenda.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The Health and Human Services Commission (HHSC) Vendor Drug Program (VDP) will update the Medicaid Preferred Drug List (PDL) on July 25. HHSC is making changes to the PDL based on recommendations agreed to at the January and April Drug Utilization Review (DUR) Board meetings. The April 26, Preferred Drug List recommendations and January 26 Preferred Drug List decisions are available for review.

Also in Texas, in advance of the July 1, 2024 deadline, NACDS submitted comments to the HHSC VDP in support of the draft policy change expanding the list of vaccines included on the Medicaid formulary. Importantly, adopting this updated policy would expand access to a broader portfolio of pharmacy provided vaccines for adults covered under the Medicaid program. NACDS also urged VDP to adjust the Medicaid pharmacy vaccine administration fee to align more closely with the administration fee that CMS has set for pharmacy-provided vaccines covered by Medicare.

Finally in Texas, the Prescription Monitoring Program (PMP) Advisory Committee met on June 27. The PMP Advisory Committee recommends to the Board of Pharmacy operational improvements, identifies data concerns and suggests methods to improve data accuracy, integrity and security.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The Health and Human Services Commission’s (HHSC) Vendor Drug Program (VDP) Medicaid is soliciting stakeholder comments about adding 14 additional vaccines to be a covered benefit for the Adult Vaccines Program. HHSC already covers influenza and COVID-19 vaccines on the Texas Medicaid formulary and proposes adding the additional vaccines listed above for adults ages 19 years and older enrolled in Medicaid. Comments are due on July 1, 2024, and must be submitted using the HHS Form 1342. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The Board of Pharmacy (TSBP) adopted and proposed several new rules at the May 7 Board meeting.

Also in Texas, the Pharmaceutical Initiative (TPI) met this week to discuss how to provide greater, more cost-effective access to prescription drugs and essential medical supplies for the health plans for state employees, retirees, Medicaid and CHIP. The three-member Board focused on developing a business plan and hiring an Executive Director.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

The Prescription Monitoring Program’s (PMP) Advisory Committee will meet via Zoom on June 27.

Also in Texas, the Health and Human Services Commission’s (HHSC) Vendor Drug Program (VDP) is hosting a Hepatitis C educational webinar on June 13. 

Finally in Texas, the Texas Pharmaceutical Initiative (TPI) Board’s next meeting will be held on June 11 at 10:00 am.  

For more information, contact NACDS’ Mary Staples at 817-442-1155.

On May 28, Texans returned to the polls for runoff elections to decide which Democratic and Republican nominees will be on the November ballot as several races failed to receive more than 50% of the vote in the primary election in March. There were eight US Congressional races, one of which is too close to call with only an 8-vote difference between the two Republican candidates vying for CD 35. In the State Senate, there were two open seats due to one retirement and one running for another office. The State House of Representatives will look much different in 2025, with nine incumbents losing in the March primaries, and seven more incumbents losing their runoffs on May 28. Of the eight Republican incumbents forced into a runoff, only Speaker Dade Phelan (R) and Dr. Gary VanDeaver (R) won their races. The chair of the House Public Health Committee and good friend of pharmacy, Stephanie Klick (R), lost her race.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

NACDS attended the Texas Conservative Coalition Research Institute’s Healthcare Policy Summit in Austin. Led by Republican Senators Pete Flores and Kelly Hancock and Representatives James Frank and Dr. Tom Oliverson, the program focused on exploring how to best expand the scope of practice for medical professionals to increase access to high-quality, affordable healthcare services for all Texans. Panelists Kevin Host with Walmart, Jay Bueche with HEB and Samatha Pickering with Walgreens, educated lawmakers and regulators on the value of pharmacists and pharmacies. A second panel addressed what steps legislators need to take to ease the regulatory burdens that drive up costs for consumers and employers.

Pictured left to right – Sen. Pete Flores (R), NACDS Chairman of the Board Kevin Host and Texas Rep. Dr. Tom Oliverson

For more information, contact NACDS’ Mary Staples at 817-442-1155.

NACDS met with Rep. Stephanie Klick (R), Chair of the House Public Health Committee, in her Ft. Worth district. The meeting in her district was a valuable opportunity to reconnect with Chair Klick thanking her for her leadership and support in promoting patient access to healthcare services. (Photo: Left to right: Mary Staples, NACDS – Cody Cribb & Stephanie McConnell, Walgreens – Texas State Rep. Stephanie Klick – Jill Lester & Jeff Loesch, Kroger). 

Also in Texas, the Texas Federation of Drug Stores held a pharmacy advocacy training program and its quarterly meeting prioritizing chain pharmacy’s 2025 legislative agenda. 

Finally in Texas, Speaker Dade Phelan (R) announced the 2024 Interim Charges for the House of Representatives. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.